Envestnet Asset Management’s Avanos Medical AVNS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-10,746
| Closed | -$121K | – | 4712 |
|
|
2025
Q4 | $121K | Sell |
10,746
-5,060
| -32% | -$57.9K | ﹤0.01% | 4347 |
|
|
2025
Q3 | $183K | Sell |
15,806
-194,431
| -92% | -$2.28M | ﹤0.01% | 4337 |
|
|
2025
Q2 | $2.57M | Buy |
210,237
+65,478
| +45% | +$823K | ﹤0.01% | 2653 |
|
|
2025
Q1 | $2.07M | Buy |
144,759
+16,192
| +13% | +$253K | ﹤0.01% | 2708 |
|
|
2024
Q4 | $2.05M | Buy |
128,567
+17,504
| +16% | +$346K | ﹤0.01% | 2674 |
|
|
2024
Q3 | $2.67M | Sell |
111,063
-3,106
| -3% | -$71K | ﹤0.01% | 2483 |
|
|
2024
Q2 | $2.27M | Sell |
114,169
-1,651
| -1% | -$32.2K | ﹤0.01% | 2519 |
|
|
2024
Q1 | $2.31M | Buy |
115,820
+7,546
| +7% | +$146K | ﹤0.01% | 2483 |
|
|
2023
Q4 | $2.43M | Buy |
108,274
+288
| +0.3% | +$5.95K | ﹤0.01% | 2343 |
|
|
2023
Q3 | $2.18M | Buy |
107,986
+29,234
| +37% | +$663K | ﹤0.01% | 2335 |
|
|
2023
Q2 | $2.01M | Sell |
78,752
-174,486
| -69% | -$4.6M | ﹤0.01% | 2276 |
|
|
2023
Q1 | $1.8M | Buy |
253,238
+191,534
| +310% | +$5.56M | ﹤0.01% | 2262 |
|
|
2022
Q4 | $1.67M | Buy |
61,704
+41
| +0.1% | +$1K | ﹤0.01% | 2290 |
|
|
2022
Q3 | $1.34M | Buy |
61,663
+4,358
| +8% | +$114K | ﹤0.01% | 2332 |
|
|
2022
Q2 | $1.57M | Sell |
57,305
-1,812
| -3% | -$52.1K | ﹤0.01% | 2260 |
|
|
2022
Q1 | $1.98M | Buy |
59,117
+11,777
| +25% | +$379K | ﹤0.01% | 2197 |
|
|
2021
Q4 | $1.64M | Buy |
47,340
+23,799
| +101% | +$769K | ﹤0.01% | 2304 |
|
|
2021
Q3 | $734K | Buy |
+23,541
| New | +$799K | ﹤0.01% | 2741 |
|
|
2021
Q1 | – | Sell |
-4,661
| Closed | -$214K | – | 3498 |
|
|
2020
Q4 | $214K | Buy |
+4,661
| New | +$194K | ﹤0.01% | 3108 |
|
|
2019
Q3 | – | Sell |
-17,108
| Closed | -$746K | – | 3077 |
|
|
2019
Q2 | $746K | Buy |
17,108
+2,613
| +18% | +$112K | ﹤0.01% | 2143 |
|
|
2019
Q1 | $619K | Buy |
14,495
+131
| +0.9% | +$5.87K | ﹤0.01% | 2201 |
|
|
2018
Q4 | $643K | Buy |
+14,364
| New | +$753K | ﹤0.01% | 1996 |
|
|
2018
Q2 | – | Sell |
-198
| Closed | -$9K | – | 2857 |
|
|
2018
Q1 | $9K | Sell |
198
-23
| -10% | -$1.09K | ﹤0.01% | 2509 |
|
|
2017
Q4 | $10K | Sell |
221
-18
| -8% | -$827 | ﹤0.01% | 2621 |
|
|
2017
Q3 | $6K | Sell |
239
-160
| -40% | -$6.83K | ﹤0.01% | 2672 |
|
|
2017
Q2 | $11K | Sell |
399
-5
| -1% | -$189 | ﹤0.01% | 2690 |
|
|
2017
Q1 | $11K | Sell |
404
-91
| -18% | -$3.55K | ﹤0.01% | 2765 |
|
|
2016
Q4 | $14K | Buy |
+495
| New | +$17.7K | ﹤0.01% | 2721 |
|
|
2016
Q3 | – | Sell |
-7,314
| Closed | -$238K | – | 2913 |
|
|
2016
Q2 | $238K | Buy |
7,314
+650
| +10% | +$19.9K | ﹤0.01% | 1998 |
|
|
2016
Q1 | $191K | Sell |
6,664
-1,964
| -23% | -$52.3K | ﹤0.01% | 2097 |
|
|
2015
Q4 | $288K | Sell |
8,628
-1,992
| -19% | -$61.9K | ﹤0.01% | 1854 |
|
|
2015
Q3 | $302K | Buy |
10,620
+3,876
| +57% | +$135K | ﹤0.01% | 1833 |
|
|
2015
Q2 | $273K | Buy |
+6,744
| New | +$303K | ﹤0.01% | 1994 |
|
Other funds holding AVNS
AC
VCM
VPM
Envestnet Asset Management's AVNS Position: Q1 2026 in Review
Envestnet Asset Management sold out of Avanos Medical (AVNS) in Q1 2026, closing a stake of 10,746 shares — an estimated $121K sold.
Envestnet Asset Management first reported a position in AVNS in Q2 2015 and held it in 33 quarters. The position peaked at $2.67M in Q3 2024. 257 funds tracked by Wall St. Rank hold AVNS as of Q1 2026.
- Envestnet Asset Management reported no remaining Avanos Medical position as of Q1 2026 after selling out during the quarter.
- Envestnet Asset Management sold 10,746 Avanos Medical shares in Q1 2026, an estimated $121K.
- Envestnet Asset Management first reported a position in Avanos Medical in Q2 2015 and held it in 33 quarters.
- Envestnet Asset Management's Avanos Medical position peaked at $2.67M in Q3 2024.
- 257 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2026.
Based on Envestnet Asset Management's 13F filing for Q1 2026, filed 4 May 2026.